Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union ...

Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

Shares of Kiran Mazumdar Shaw-led Biocon extended gains to settle five per cent higher on Tuesday, December 24, after the ...

Biocon shares had gained earlier in the day after the company and its European partner Zentiva received a decentralised ...

The drug, developed by researchers at Japanese biotech firm Toregem Biopharma, targets a protein in the human body known as ...

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

Bangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...

Bengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from ...

Biocon and Zentiva gain EU approval for generic Liraglutide, marking milestone in expanding complex generic medication ...

Biocon Limited, alongside its European partner Zentiva, has successfully obtained approval for their generic version of ...

Biocon and Zentiva receive EU approval for generic versions of Victoza (diabetes) and Saxenda (weight management). This marks ...